Skip to main content
Erschienen in: Indian Journal of Hematology and Blood Transfusion 2/2022

15.01.2022 | Images

NK-Lymphoblastic Leukemia/Lymphoma: An Enigma

verfasst von: Karthik Srevatsa, Garima Jain, Deepam Pushpam, Aparna Ningombam, Anita Chopra

Erschienen in: Indian Journal of Hematology and Blood Transfusion | Ausgabe 2/2022

Einloggen, um Zugang zu erhalten

Excerpt

A 59-year-old man was investigated for fever, headache, and blurring of vision. On physical examination, he had hepatosplenomegaly. PET/CT revealed multiple intra-thoracic and intra-abdominal lymphadenopathy. A complete blood count showed leucocytosis (90.4 × 109 /L) with anemia (9.8 g/dL) and thrombocytopenia (77 × 109/L). The peripheral blood smear showed the presence of 75% pleomorphic, medium- to large-sized atypical cells with mostly irregularly shaped nuclei, high nuclear/cytoplasmic ratio, and immature, blastic chromatin with multiple nucleoli (Fig. 1A). Bone marrow examination revealed infiltration by 80% of similar morphology cells. On immunophenotyping, these cells were: CD45bright+/CD2+/CD7+/CD43dim+/CD94+/cytoplasmicCD3/CD5/CD28/CD4/CD8/TdT/CD19/CD10/CD117/CD33/CD13/CD56/Perforin/TCRαβ/TCRγδ/HLA-DR+/cytoplasmicCD79a/CD30 /CD57 /CD16/CD11c/CD25/cytoplasmic MPO/CD64 /CD14. This suggested a diagnosis of Natural Killer (NK) cell lymphoblastic leukemia/lymphoma. The patient was started on cyclophosphamide, dexamethasone, and etoposide. However, he developed tumor lysis syndrome and succumbed to the disease.
Metadaten
Titel
NK-Lymphoblastic Leukemia/Lymphoma: An Enigma
verfasst von
Karthik Srevatsa
Garima Jain
Deepam Pushpam
Aparna Ningombam
Anita Chopra
Publikationsdatum
15.01.2022
Verlag
Springer India
Erschienen in
Indian Journal of Hematology and Blood Transfusion / Ausgabe 2/2022
Print ISSN: 0971-4502
Elektronische ISSN: 0974-0449
DOI
https://doi.org/10.1007/s12288-021-01511-z

Weitere Artikel der Ausgabe 2/2022

Indian Journal of Hematology and Blood Transfusion 2/2022 Zur Ausgabe

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.